Výsledky vyhledávání - "MESH : Carcinoma, Small Cell"

Economics of the clinical management of lung cancer in France: an analysis using a Markov model

Autor: Laurent Molinier, Christophe Combescure, Bruno Housset, Jean-Pierre Daurès, Christos Chouaid, A. Vergnenegre

Publikováno v: British Journal of Cancer
British Journal of Cancer, Cancer Research UK, 2004, 90 (2), pp.397-402. ⟨10.1038/sj.bjc.6601547⟩
British Journal of Cancer, 2004, 90 (2), pp.397-402. ⟨10.1038/sj.bjc.6601547⟩

International audience; To evaluate, according to the histologic type and initial stage, the mean cost (MC) of managing patients with lung cancer and the costs of the different management phases. A Markov approach was used to model these costs, based

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ad63cc9c5a5105819c872abbe8bf63c
https://doi.org/10.1038/sj.bjc.6601547

Zobrazit plný text záznamu

Lung cancer risk among bricklayers in a pooled analysis of case-control studies

Autor: Consonni, Dario, De Matteis, Sara, Pesatori, Angela C, Bertazzi, Pier Alberto, Olsson, Ann C, Kromhout, Hans, Peters, Susan, Vermeulen, Roel Ch, Pesch, Beate, Brüning, Thomas, Kendzia, Benjamin, Behrens, Thomas, Stücker, Isabelle, Guida, Florence, Wichmann, Heinz-Erich, Brüske, Irene, Landi, Maria Teresa, Caporaso, Neil E, Gustavsson, Per, Plato, Nils, Tse, Lap Ah, Yu, Ignatius Tak-Sun, Jöckel, Karl-Heinz, Ahrens, Wolfgang, Pohlabeln, Hermann, Merletti, Franco, Richiardi, Lorenzo, Simonato, Lorenzo, Forastiere, Francesco, Siemiatycki, Jack, Parent, Marie-Élise, Tardón, Adonina, Boffetta, Paolo, Zaridze, David, Chen, Ying, Field, John K, 't Mannetje, Andrea, Pearce, Neil, McLaughlin, John, Demers, Paul, Lissowska, Jolanta, Szeszenia-Dabrowska, Neonila, Bencko, Vladimir, Foretova, Lenka, Janout, Vladimir, Rudnai, Peter, Fabiánová, Eleonóra, Stanescu Dumitru, Rodica, Bueno-de-Mesquita, Bas, Schüz, Joachim, Straif, Kurt, Risk Assessment, Infection & Immunity, dIRAS RA-2, dIRAS RA-I&I RA, LS IRAS EEPI EXAS (Arb.hyg+bl.st.kar.), LS IRAS EEPI GRA (Gezh.risico-analyse)

Publikováno v: International Journal of Cancer, 136(2), 360. Wiley-Liss Inc.
International Journal of Cancer
International Journal of Cancer, 2015, 136 (2), pp.360-71. ⟨10.1002/ijc.28986⟩
International Journal of Cancer, Wiley, 2015, 136 (2), pp.360-71. ⟨10.1002/ijc.28986⟩
International journal of cancer, 136(2): 360-371
International Journal of Cancer. Journal International du Cancer

Bricklayers may be exposed to several lung carcinogens, including crystalline silica and asbestos. Previous studies that analyzed lung cancer risk among these workers had several study design limitations. We examined lung cancer risk among bricklayer

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4eb5248be15e82b9cec18d438aa5c199
http://hdl.handle.net/11585/672235

Zobrazit plný text záznamu

Use of tumor markers for differential diagnosis of mesothelioma and secondary pleural malignancies

Autor: Bruno Housset, Christos Chouaid, Jean-Paul Tillement, K. Atassi, Isabelle Monnet, Claire Fuhrman, Jean-Claude Duché, I Abd Alsamad

Publikováno v: Clinical Biochemistry
Clinical Biochemistry, Elsevier, 2000, 33 (5), pp.405-10
Clinical Biochemistry, 2000, 33 (5), pp.405-10

International audience; STUDY OBJECTIVE: The aim of the study was to assess diagnosis value of tumor markers for differential diagnosis between mesothelioma and other pleural tumors. DESIGN AND METHODS: Prospective study of 85 patients attending our

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44e0c36dc079c8f3a1b8866340c3f334
https://doi.org/10.1016/s0009-9120(00)00157-0

Zobrazit plný text záznamu

Phase III double-blind, placebo-controlled study of thalidomide in extensive-disease small-cell lung cancer after response to chemotherapy: an intergroup study FNCLCC cleo04 IFCT 00-01

Autor: Jean Luc Breton, Virginie Westeel, Elisabeth Quoix, Dominique Maraninchi, Sabine Gameroff, Radj Gervais, Jean-Louis Pujol, H. Janicot, Philippe David, Jean Genève, Marie-Laure Tanguy

Publikováno v: Journal of Clinical Oncology
Journal of Clinical Oncology, 2007, 25 (25), pp.3945-51. ⟨10.1200/JCO.2007.11.8109⟩
Journal of Clinical Oncology, American Society of Clinical Oncology, 2007, 25 (25), pp.3945-51. 〈10.1200/JCO.2007.11.8109〉
Journal of Clinical Oncology, American Society of Clinical Oncology, 2007, 25 (25), pp.3945-51. ⟨10.1200/JCO.2007.11.8109⟩

Purpose This randomized, double-blind, placebo-controlled phase III study aimed to determine whether thalidomide prolongs survival of patients with extensive-disease small-cell lung cancer (SCLC). Patients and Methods One hundred nineteen patients re

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5feb95fe855a6a2a5e37d7d2b56abf84
https://hal.science/hal-00484930

Zobrazit plný text záznamu

[The progression of lung cancer incidence in France (1978-2000)]

Autor: Molinié, F., Velten, M., Remontet, L., Bercelli, P., Réseau Francim, Danzon, Arlette

Publikováno v: Revue des Maladies Respiratoires
Revue des Maladies Respiratoires, 2006, 23 (2 Pt 1), pp.127-134
Revue des Maladies Respiratoires, Elsevier Masson, 2006, 23 (2 Pt 1), pp.127-134

International audience; INTRODUCTION: Lung cancer is the most common cause of death from malignant disease in the world. Our objective was to describe the progression of this cancer's incidence, and the changing distribution of histological types in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::bf4790e88a12efd5026bed5a65bba82e
https://hal.science/hal-00486788

Zobrazit plný text záznamu

Routine use of granulocyte colony-stimulating factor is not cost-effective and does not increase patient comfort in the treatment of small-cell lung cancer: an analysis using a Markov model

Autor: Bruno Housset, Christos Chouaid, Claire Fuhrman, Isabelle Monnet, L Bassinet

Publikováno v: Journal of Clinical Oncology
Journal of Clinical Oncology, American Society of Clinical Oncology, 1998, 16 (8), pp.2700-7
HAL
Journal of Clinical Oncology, 1998, 16 (8), pp.2700-7

PURPOSE The clinical indications and economic consequences of human granulocyte colony-stimulating factor (G-CSF) prescription during small-cell lung cancer (SCLC) chemotherapy remain controversial. The aim of this study, based on a Markov model, was

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f33dfed4d276cf8c333ef9445bae4f88
https://doi.org/10.1200/jco.1998.16.8.2700

Zobrazit plný text záznamu

Prognosis of lung cancer patients with life-threatening complications

Autor: Jorge I. F. Salluh, Elie Azoulay, Nelson Spector, Guillaume Thiery, Michael Darmon, Carlos Gil Ferreira, Benoît Schlemmer, Marcio Soares

Publikováno v: Chest
Chest, American College of Chest Physicians, 2007, 131 (3), pp.840-6. ⟨10.1378/chest.06-2244⟩

International audience; BACKGROUND: The management of patients with lung cancer has improved recently, and many of them will require admission to the ICU. The aims of this study were to determine hospital mortality and to identify risk factors for de

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c61276aafc55db4b55cbaab83e58751d
https://www.hal.inserm.fr/inserm-00349094

Zobrazit plný text záznamu

[Randomised phase II study evaluating oral combination chemotherapy (CCNU, cyclophosphamide, etoposide) and intravenous chemotherapy as second-line treatment for relapsed small cell bronchial carcinoma (Trial GFPC0501)]

Autor: Gervais, R., Le Guen, Y., Le Caer, H., Paillotin, D., Chouaid, C., Renseigné, Non

Publikováno v: Revue des Maladies Respiratoires
Revue des Maladies Respiratoires, 2007, 24 (5), pp.653-8

International audience; BACKGROUND: There is no standard second-line treatment for small cell lung cancer (SCLC). The prognosis of these patients is poor and special attention should be paid to both quality of life and economic factors. METHODS: The

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::53c1d96d612c9a0d71bb11d5a93cc4b0
https://hal.sorbonne-universite.fr/hal-00597115

Zobrazit plný text záznamu

[Pemetrexed development in oncology]

Autor: Chaigneau, Loïc, Villanueva, Christian, Thierry-Vuillemin, Antoine, Legat-Fagnoni, Christine, N'Guyen, Thierry, Maurina, Tristan, Lorgis, Véronique, Pivot, Xavier

Publikováno v: Bulletin du Cancer
Bulletin du Cancer, John Libbey Eurotext, 2007, 94 Spec No Actualites, pp.S142-8

International audience; The pemetrexed disodium (Alimta), LY231514) is the first antifolate able to inhibit at the same time the synthesis of purins and pyrimidins. Many therapeutic tests were carried out in clinical situations where the methotrexate

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::7da2a4106560374843590b60d53ab0fa
https://www.hal.inserm.fr/inserm-00479715

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání